Hydrogen Sulfide Is a Regulator of Hemoglobin Oxygen-Carrying Capacity via Controlling 2,3-BPG Production in Erythrocytes.

Hydrogen sulfide (HS) is naturally synthesized in a wide range of mammalian tissues. Whether HS is involved in the regulation of erythrocyte functions remains unknown. Using mice with a genetic deficiency in a HS natural synthesis enzyme cystathionine--lyase (CSE) and high-throughput metabolomic profiling, we found that levels of erythrocyte 2,3-bisphosphoglycerate (2,3-BPG), an erythroid-specific metabolite negatively regulating hemoglobin- (Hb-) oxygen (O) binding affinity, were increased in CSE knockout ( ) mice under normoxia. Consistently, the 50% oxygen saturation (P50) value was increased in erythrocytes of mice. These effects were reversed by treatment with HS donor GYY4137. In the models of cultured mouse and human erythrocytes, we found that HS directly acts on erythrocytes to decrease 2,3-BPG production, thereby enhancing Hb-O binding affinity. Mouse genetic studies showed that HS produced by peripheral tissues has a tonic inhibitory effect on 2,3-BPG production and consequently maintains Hb-O binding affinity in erythrocytes. We further revealed that HS promotes Hb release from the membrane to the cytosol and consequently enhances bisphosphoglycerate mutase (BPGM) anchoring to the membrane. These processes might be associated with S-sulfhydration of Hb. Moreover, hypoxia decreased the circulatory HS level and increased the erythrocyte 2,3-BPG content in mice, which could be reversed by GYY4137 treatment. Altogether, our study revealed a novel signaling pathway that regulates oxygen-carrying capacity in erythrocytes and highlights a previously unrecognized role of HS in erythrocyte 2,3-BPG production.